A forensic standard procedure is described that combines enzyme-linked immunoassay for screening and gas chromatography-mass spectrometry (GC-MS) for confirmation to detect drugs of abuse in a sample before used to detect opioids and cocaine. We used two equal aliquots of the same previously selected cannabinoid positive hair samples, one of which was subjected to acid hydrolysis. Afterward, both the aliquots were subjected to basic extraction and then to immunoassay screening. After derivatization, the GC-MS parameters were the same for both the aliquots for the determination of the cannabinoids (Δ 9 -tetrahydrocannabinol, cannabidiol and cannabinol). The results show that there were no statistical differences between the nonpreviously treated and the pretreated hair samples for the quantification of the three cannabis products for immunochemical procedure. No differences between the two groups were shown as for GC-MS confirmation procedures. All substances showed a good linearity between 0.05 and 2 ng/mg. The limit of detection ranged from 0.02 to 0.03 ng/mg, and the limit of quantification was 0.05 ng/mg for all substances. To our knowledge, this is the first time that screening and confirmation procedures have been applied on the same sample of hair to detect more than one drug of abuse.
Introduction
The abuse of recreational drugs is becoming a problem of growing interest in many countries in the world. Consequently, demand for the evaluation of drug abuse is increasing, mostly for court trials, postmortem toxicology, driving license renewals, workplace, especially in hair matrix. In forensic toxicological analysis in situations where there is a requirement for a high volume of hair tests or two different techniques in order for the results to be forensically acceptable, immunoassay screening is commonly used for the initial screening. Positive results using this analytical method must be unambiguously confirmed using more sensitive and specific techniques like gas chromatographymass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS). Most techniques of detection of drug of abuse in hair currently in use require a sample of 10-50 mg for analytes, according to the international guidelines for hair analysis (1) . Furthermore, commonly more than one drug of abuse or compounds of forensic interest need to be checked on a single sample, some of which must be stored for retesting, if necessary (technical or procedural errors, confirmation tests). In particular, in our laboratory, it is generally required, from the same sample, to determine the presence of cocaine, opiates and Δ 9 -tetrahydrocannabinol (Δ 9 -THC) (driving license renewals or workplace test). Cannabis products are today one of the most commonly consumed drugs in the world, especially by young people (2) . For this reason, the active cannabis constituent (Δ 9 -THC) and the nonactive substances, cannabidiol (CBD) and cannabinol (CBN), are always required. The evidence of cannabis use could be obtained also by testing for the presence of metabolite 11-nor-Δ 9 -tetrahydrocannabinol-9-carboxylic acid (Δ 9 -THC-COOH) (3) . Moreover, Δ 9 -THC-COOH is incorporated in hair with very low efficiency (3) (4) (5) (6) . Due to the scarce incorporation of this cannabis metabolite in hair matrix, the concentrations of Δ 9 -THC-COOH are generally lower than the detection limit of most of the GC-MS methods routinely employed for drug of abuse analysis (3, 4) . It is common practice to determine Δ 9 -THC, CBD and CBN and subsequently to detect Δ 9 -THC-COOH in cases of objection to the results (3), by using a more sensitive technique like GC-MS-MS or LC-MS-MS.
Moreover, the amount of hair sample available for analysis is frequently limited; so, it is important to develop a sample preparation procedure capable of detecting more drugs of abuse with different chemical characteristics on a single amount of hair (7) (8) (9) . This study describes a procedure for the detection of cannabis products (Δ 9 -THC, CBD and CBN) in a hair sample previously subjected to an acid hydrolysis to detect opiates and cocaine and their metabolites. According to some authors, the use of acid hydrolysis procedures could produce a considerable decrease in the extraction rate for Δ 9 -THC in hair (10) . For this reason, in order to assess the efficacy of the method, we compared the results of samples divided into two aliquots, one of which was previously subjected to acid hydrolysis used to detect cocaine and opiates (11) . This sample and the other not previously treated part of hair were subjected to direct alkaline digestion (12) and liquid extraction. Both aliquots were subjected to a standard forensic analysis procedure using immunochemical and GC-MS techniques. The procedure described allows us to use a smaller amount of hair to detect the three drugs of abuse.
Materials and methods

Chemicals and reagents
The enzyme-linked immunoabsorbent assay kits for Δ 9 -THC (#224), the Hair Extraction Buffer and the Neutralizing Buffer were obtained from Immunalysis Corporation (Pomona, CA, USA). Δ 9 THC-D 3 (internal standard (IS) for THC), Δ 9 -THC, CBN and CBD (1 mg/mL in methanol, for validation) were purchased from Sigma-Aldrich. Hydrochloric acid, hexane, dichloromethane, ethyl acetate, cyclohexane and sodium hydroxide were obtained from Panreac. The silylation reagent N, O-bis-(trimethylsilyl)-trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS) was purchased from Sigma-Aldrich.
Sample preparation
The samples used in this study formed a hair pool (n = 60), including which had previously resulted positive (n = 40) or negative (n = 20) for cannabinoids in our laboratory. The samples had been collected from the posterior vertex area, washed two times with dichloromethane. The second wash solutions had been tested to exclude external contamination. The samples (4 cm long) were manually cut into small fragments for the detection of drugs and divided into two aliquots of the same weight (50 mg). One aliquot of the single sample was incubated overnight in 2 mL of 0.1 M HCl solution at 50°C. The resulting mixtures were cooled at room temperature, neutralized with 2 mL of phosphate buffer solution, pH 6, and NaOH 2 M at pH 6-7 was added, as if being extracted with an solid phase extraction technique for cocaine and opiates detection (13) . The aliquot of non-previously treated samples (Group A) and the other aliquot pretreated with acid hydrolysis (Group B) were subjected to basic hydrolysis (NaOH 1 M solution, at 95°C for 15 min), cooled at room temperature and extracted using a liquid-liquid method. Three milliliters of an extraction solution of n-hexane/ethyl acetate (9 : 1) was added to both the samples and agitated for at least 15 min. The organic phases were separated, then completely evaporated and finally a solution of 0.5 mL of Extraction Buffer with 50 µL of Neutralization Buffer was added.
An aliquot of 30 µL was used for enzyme-linked immunoassay (ELISA) analysis, in accordance with the manufacturer's instructions (14) . At the end of the analysis, the samples, to which IS (50 ng of Δ 9 -THC-D 3 ) was added, were completely evaporated, then 30 µL of BSTFA + 1% TMCS was added at 60°C for 30 min. One microliter of BSTFA + 1% TMCS was injected in GC-MS.
Immunochemical analysis
The cannabinoid ELISA Kit from the Immunalysis Corporation is a heterogeneous competitive enzyme immunoassay that was originally designed to detect cannabinoids in saliva/oral fluid. It was adapted and validated for cannabinoids in human hair (13) . We used immunoanalysis procedures according to the manufacturer's instructions. The samples were analyzed by means of a fully automatic system (DSX automatic ELISA system) that measures average absorbance of a dual wavelength of 450 and 650 nm. The sample is considered positive if this value is equal to or less than the Δ 9 -THC absorbance value of the laboratory (0.1 ng/mg, Society of Hair Testing (SoHT) cutoff (1)). When the average sample absorbance is greater than the laboratory values, the sample is considered negative. A dose-response curve was developed by standard concentrations.
GC-MS instrumental and analytical condition
The ISQ single quadruple GC-MS (Thermo Scientific™, Waltham, MA, USA) analytical conditions for drug analysis were equipped with a wall-coated open-tubular capillary column (Zebron™ ZB-5MS (Phenomenex, Torrance, CA, USA) fused silica 20 m × 0.18 mm × 0.18 μm). The carrier gas was helium at flow rate of 1.0 mL/ min. The temperature program started at 100°C for 1 min, increased first at 250°C at 40°C/min for 4 min and then to 320°C at 20°C/min. The injection volume was 1 µL in splitless mode for 1 min. Electron ionization (70 eV) was used; mass spectra range was 280-410.
The analyses were performed by monitoring ions m/z 386, 371, 315 for Δ 9 -THC-TMS, m/z 374, 315, 389 for Δ 9 -THC-D 3 -TMS, m/z 367, 368, 382 for CBN-TMS and m/z 390, 337, 301 CBD-TMS. For the determination of positivity were used the cutoff values proposed by the SoHT (1). For quantification, peak-area ratios of the analytes to those of IS were calculated.
Method validation
The reported method was validated for calibration/linearity, quantification limits [limit of detection (LOD) and limit of quantitation (LOQ)], precision and recovery according to internationally recognized Scientific Working Group for Forensic Toxicology (SWGFT) guidelines (15) .
Calibration/linearity
Standard curves for Δ 9 -THC, CBD and CBN using negative hair samples fortified with six concentration points with three replicates for each, 0.05, 0.1, 0.2, 0.5, 1 and 2 ng/mg, were prepared for GC-MS.
The area (analyte)/area (IS) was plotted against the known concentrations of the standard solutions to establish calibration equations. A linear regression equation was calculated using the least squares method.
Preparation and conservation of the calibrating samples Each analytical day, calibrating samples were prepared by fortifying negative hair samples (50 mg) with 0.05, 0.1, 0.2, 0.5, 1 and 2 ng/ mg of Δ 9 -THC, CBN and CBD from working solutions. Stock solutions and ISs were stored at −20°C.
LOD and LOQ LOD was determined based on the standard deviation of y-intercepts and the average slope of regression lines [(3.3s y )/Avg m ].
LOQ value is the lowest concentration that shows acceptable value of bias (±20%) and precision (coefficient of variation (CV) ≤ 20%).
Precision and accuracy
Intraday trueness (accuracy) (%Bias) and precision (%CV) were assessed using concentrations just above and just below the standard curves, 0.5 and 5 ng/mg, with three replicates for each concentration.
Interday accuracy was calculated using the three replicates at each concentration on each day for 5 days.
%Bias and %CV values in the range of ±15% (20% near the LOQ) were considered acceptable.
Recovery
The extraction efficiency was calculated as absolute recovery. Six samples were analyzed at two concentration levels (0.1 and 1 ng/mg); analytes and IS were fortified after extraction. A further six samples were analyzed at the same concentrations, but the analytes were fortified before extraction, while IS after extraction.
Results
Results of validation process
Linearity was observed for Δ 9 -THC concentrations ranging from 0.05 to 2.0 ng/mg with a correlation coefficient of 0.9933. The limit of detention in GC-MS of Δ 9 -THC, CBD and CBN was 0.02, 0.03 and 0.03 respectively (see Table I ).
The residual plots confirmed random distribution of individual residuals around the zero lines (homoscedasticity); thus, it was not necessary to weigh the least square regression. Δ 9 -THC mean values of extraction recoveries were 71.26% at 1 ng/mg concentration and 72.98% at 0.1 ng/mg. The mean value of extraction recoveries for CBD registered 68.10% at 1 ng/mg concentration and 65.24% at 0.1 ng/mg. The mean value of extraction recoveries for CBN registered 75.42% at 1 ng/mg concentration and 71.67% at 0.1 ng/mg.
Results of ELISA and GC-MS analysis
A total of 40 real cannabinoids positive and 20 negative hair samples were analyzed by ELISA immunoassay and subsequently by means of GC-MS. The statistical comparison of the immunochemical results using the paired t-test shows no significant differences between the mean values of concentration for positive samples of Group A versus Group B (t-test observed = 1.53, t-test calculated = 2.02, ns). All confirmed negative samples were lower than the cutoff value. Figure 1 shows the typical GC-MS chromatogram obtained from a positive Δ 9 -THC sample.
Considering the drug concentrations, the results of the GC-MS sample data analysis show the almost constant presence of all the cannabis substances for both groups. Only in one case, CBD was not detected (direct method, Group A), but was detected with double extraction (Group B). Table II shows the range and mean concentration of each of the three drugs in GC-MS for Groups A and B. The data analysis, inside the single group, shows that Δ 9 -THC was less concentrated than CBN for both groups but more than CBD. The comparison between the two groups shows that, notwithstanding the fact that the mean values of concentration of Group B were higher than those of Group A, the differences do not reach a statistically significant level for any of the three cannabinoids (Δ 9 -THC Group A versus Group B: t(78) = 1.24, ns; CBN Group A versus Group B: t(78) = 1.42, ns; CBD Group A versus Group B: t(78) = 0.20, ns).
All negative samples in immunoassay were confirmed in GC-MS. We tried to analyze the consumption behavior of cannabis users by applying Kauert's proposal (10) that compares the concentration of Δ 9 -THC in hair with the pattern of use. Table III shows the results of the distribution of our Δ 9 -THC positive hair samples of Groups A and B.
Discussion
Hair analysis is a very useful tool for evaluating drug exposure, especially in cases of polydrug abuse. According to the literature, few methods have been developed that enable detection of multiclass drugs (8, 9, 16, 17) , and only one has been able to determine Δ 9 -THC substance in GC-MS (8) .
This article describes a method to analyze more drug of abuse in situations presenting a limited amount of sample using a sample residual from acid hydrolysis with the same efficiency as classic basic hydrolysis. Moreover, the method confirms its validity in a standard forensic procedure involving immunoanalysis screening followed by a GC-MS confirmation of positive data. The validation values are lower than the cutoff, suggested by the SoHT (0.1 ng/mg) (1), used to define positive sample in this study. The Δ 9 -THC value was also suitable for detecting occasional cannabis use, as shown in the literature (3, 18) . The higher than 70% of Δ 9 -THC recovery was similar to that of other studies found in the literature using polypropylene tubes, just as we did (3, 5) .
Literature presents no standardized washing methods, although various approaches have been proposed, such as dichloromethane, methanol and phosphate buffer (19) (20) (21) . In this study, we used dichloromethane washing because, according some authors, organic solvents such as dichloromethane can only remove the oily residues and contaminations on the surface, while aqueous solutions or methanol may swell the hair and remove the drugs from the inside of the matrix (22) : water expands the cuticle and proteins in the hair, facilitating permeability (1). Moreover, it has been shown that decontamination methods may influence the final recovery of the substance, leading to the result that washing with dichloromethane extracts <2% of the internal substance (22, 23) . The absence of statistical differences of GC-MS concentrations of the two groups shows that acid digestion does not produce a Δ 9 -THC loss as shown in results presented in literature, but there is an improvement in the three cannabinoid mean values. Our results show that, for both groups, CBN mean values are superior to those of Δ 9 -THC confirming literature data, probably formed from dehydrogenation of Δ 9 -THC during combustion (3, 5) . According to some authors, there is evidence that a small part of CBD is cyclized into Δ 9 -THC during the same combustion process, suggesting that the sum of the three cannabinoids provides a better measure of drug use than only Δ 9 -THC (24) . Our data show that the mean data values of the three cannabinoid substances are superior to those presented in literature using a similar technique (liquid extraction-GC-MS) (5) . This could be due to a higher amount of content in cannabis plants seized in Italy in the last few years (25) (26) (27) . It is a matter of debate if the amount of cannabinoids in hair analysis can indicate an individual's drug consumption behavior. We are not in a possession of any data about self-reported drug use, so we are not in a position to comment on this. According to a proposal by some authors which can be found in literature, 0.1-1.0 ng/mg hair range of concentration of Δ 9 -THC would suggest weekly or daily consumption (10) . Higher concentrations than this range appear to be linked to multiple daily use, while lower concentrations indicate a pattern of occasional use. Our results showed no differences between the two groups regarding patterns of use. For both groups, most of the Δ 9 -THC concentrations is in the middle range, indicating a daily or weekly assumption (63%), only ∼10% used cannabis occasionally. In contrast, ∼27% were heavy consumers. These data are partially different from those of the few studies in literature that deal with patterns of cannabis drug use. According to an European Monitoring Centre for Drugs and Drug Addiction report, occasional consumers are less representative (28%), while daily and heavier users are equally representative (both 36%) (28, 29) . The low amount of occasional consumers could be due to the fact that a considerable portion of occasional users are not detectable with a cutoff of 0.1 ng/mg THC in hair. On the contrary, the difference could be explained in the light of certain considerations. In Italy, cannabis consumption is lower than in other European countries (28, 30) . Moreover, recently, an increase has been observed in the amount of Δ 9 -THC in herbal cannabis (25) (26) (27) .
Conclusion
We have developed and validated a reliable method, which can be easily performed in most analytical and in most toxicological laboratories. It has been shown to be suitable for analyzing more than a single drug, when sample volumes may constitute a limiting factor in analytical procedures. Moreover, the method enables detection of the three cannabinoids for confirmation of the results. To our knowledge, this is the first time that a standard forensic procedure (immunochemical for screening and GC-MS for confirmation) could be applied with a single hair sample.
